Phase 3 Clinical Study of JTE-061 Cream - 52-week Long-term Study in Patients with Plaque Psoriasis

emoto Takanori0 个研究点目标入组 300 人开始时间: 2021年8月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Japanese patients aged >= 18 years at informed consent who can visit the study site as an outpatient
•2. Patients with clinical diagnosis of chronic plaque psoriasis and stable disease for at least 6 months at informed consent
•3. Patients whose PGA score, PASI score, and %BSA affected meet the criteria specified in the study protocol

•1. Patients with psoriasis other than plaque variant
•2. Patients with a history of or current significant dermatologic or inflammatory condition that, in the investigator's opinion, would make it difficult to interpret data or assessments during the study
•3. Patients with a history of or current acute active bacterial, fungal, or viral (e.g., herpes simplex, herpes zoster, and varicella) skin infection within 1 week prior to Week 0
•4. Patients who have used any prohibited therapy specified in the study protocol within the indicated period before Week 0
•5. Patients with serious concomitant disease(s)
•6. Patients with a history of or current cancer within 5 years prior to screening visit

发起方

emoto Takanori